Suppr超能文献

用于四环素霉素F2生物合成的迭代型II聚酮合酶的重构。

Reconstitution of the iterative type II polyketide synthase for tetracenomycin F2 biosynthesis.

作者信息

Bao W, Wendt-Pienkowski E, Hutchinson C R

机构信息

School of Pharmacy, Department of Bacteriology, University of Wisconsin, Madison 53706, USA.

出版信息

Biochemistry. 1998 Jun 2;37(22):8132-8. doi: 10.1021/bi980466i.

Abstract

The tetracenomycin polyketide synthase (TCM PKS), a type II complex, produces TCM F2, a precursor of TCM C in Streptomyces glaucescens, and consists of at least the TcmK, -L, -M, and -N proteins. The TcmK/TcmL ketosynthase subunits were purified from overexpression of their genes in Streptomyces lividans. TcmK (calculated molecular mass 45 kd) and TcmL (calculated molecular mass 42 kd) function as a heterodimeric alphabeta complex based on observing that only the purified complex complemented TCM PKS activity in protein extracts made from strains bearing tcmK or tcmL deletion mutants to make TCM F2 in vitro, and that the molecular mass of the purified complex was 90 kd as estimated by gel filtration chromatography. The TCM PKS activity was reconstituted with purified protein components, indicating that the minimal set of proteins required to make TCM F2 included the ketosynthase complex (TcmKL), an acyl carrier protein (TcmM), a malonyl CoA:ACP acyltransferase (MAT), and a cyclase (TcmN). The MAT was required to catalyze the transacylation between malonyl-CoA and TcmM, although a relatively slow spontaneous transacylation also occurred in a reaction without the MAT. Acetyl-CoA, the proposed starter unit for the TCM PKS, was not required for the production of TCM F2 in vitro, although it could be incorporated into this polyketide to a small extent. TcmJ, a PKS protein without a known function, greatly increased the production of TCM F2 but could not replace TcmN as a cyclase in the reconstituted system.

摘要

四并苯霉素聚酮合酶(TCM PKS)是一种II型复合物,在浅青紫链霉菌中产生TCM F2(TCM C的前体),并且至少由TcmK、-L、-M和-N蛋白组成。TcmK/TcmL酮合成酶亚基是从它们在变铅青链霉菌中的基因过表达中纯化得到的。基于观察到只有纯化的复合物能在由携带tcmK或tcmL缺失突变体的菌株制备的蛋白提取物中补充TCM PKS活性以在体外产生TCM F2,并且通过凝胶过滤色谱估计纯化复合物的分子量为90 kd,TcmK(计算分子量45 kd)和TcmL(计算分子量42 kd)作为异源二聚体αβ复合物发挥作用。用纯化的蛋白质组分重建了TCM PKS活性,这表明产生TCM F2所需的最小蛋白质组包括酮合成酶复合物(TcmKL)、酰基载体蛋白(TcmM)、丙二酰辅酶A:ACP酰基转移酶(MAT)和环化酶(TcmN)。MAT是催化丙二酰辅酶A与TcmM之间转酰基作用所必需的,尽管在没有MAT的反应中也会发生相对缓慢的自发转酰基作用。虽然乙酰辅酶A(被认为是TCM PKS的起始单元)在体外产生TCM F2时不是必需的,但它可以少量掺入这种聚酮化合物中。TcmJ是一种功能未知的PKS蛋白,它极大地增加了TCM F2的产量,但在重建系统中不能替代TcmN作为环化酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验